ClinicalTrials.Veeva

Menu

A Study Comparing Two Topicals in the Treatment of Acne Vulgaris

Vyne Therapeutics logo

Vyne Therapeutics

Status and phase

Completed
Phase 1

Conditions

Acne Vulgaris

Treatments

Other: Hydro-alcohol solution
Drug: FMX101 vehicle

Study type

Interventional

Funder types

Industry

Identifiers

NCT03743038
FX2018-23

Details and patient eligibility

About

A Randomized, Evaluator-Blinded, Bilateral Comparison Study to Evaluate the Safety and Efficacy of Two Topicals in the Treatment of Subjects With Acne Vulgaris (Study FX2018-23).

Full description

A Randomized, Evaluator-Blinded, Bilateral Comparison Study to Evaluate the Safety and Efficacy of Two Topicals in the Treatment of Subjects With Acne Vulgaris. Eligible subjects will be randomized (1:1) to treatment with Test Article A to one side of the face versus Test Article B on the contralateral side.

Enrollment

12 patients

Sex

All

Ages

12 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Has facial acne vulgaris with:

    16 inflammatory lesions (papules, pustules) The inflammatory lesion count on the right and left side of the face should be similar IGA score of moderate (3) on both the right and left side of the face

Exclusion criteria

  • Acne conglobata, acne fulminans, secondary acne (chloracne, drug-induced acne), or any dermatological condition of the face or facial hair (eg, beard, sideburns, mustache) that could interfere with the clinical evaluations.
  • More than two facial nodules/cysts
  • Sunburn on the face

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

12 participants in 2 patient groups

FMX101 vehicle
Experimental group
Description:
FMX101 hydrophobic oil based vehicle (Test Article A) topically applied daily for six weeks on one side of the face (in a split-face model)
Treatment:
Drug: FMX101 vehicle
Hydro-alcohol solution base
Experimental group
Description:
Hydro-alcohol solution based vehicle (Test Article B) topically applied daily for six weeks on the contralateral side of the face (in a split-face model)
Treatment:
Other: Hydro-alcohol solution

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems